[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340218-105":59,"doc-detail-340218-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-double-edged-sword-property-of-mesenchymal-stem-cell-derived-exosomal-micrornas-in-colorectal-cancer-review-gastrointestinal-tract","The Double-Edged Sword Property of Mesenchymal Stem Cell-Derived Exosomal microRNAs in Colorectal Cancer - Review Gastrointestinal Tract","","Mesenchymal stem cells (MSCs)-based therapies are promising strategies for cancer treatment due to their immunomodulatory and tissue-regeneration capabilities. In colorectal cancer (CRC), MSCs show a double-edged effect: some studies report inhibition of cancer-cell proliferation, migration, and invasion, while others report tumor-promoting roles in CRC progression. Exosomal microRNAs (Exo-miRs) derived from MSCs have been linked to this paradoxical activity. This review examines MSC-derived Exo-miRs roles in CRC progression and evaluates their therapeutic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-double-edged-sword-property-of-mesenchymal-stem-cell-derived-exosomal-micrornas-in-colorectal-cancer-review-gastrointestinal-tract/340218/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-double-edged-sword-property-of-mesenchymal-stem-cell-derived-exosomal-micrornas-in-colorectal-cancer-review-gastrointestinal-tract/340218.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are mesenchymal stem cell (MSC)-based therapies considered promising for cancer treatment?","Question",{"text":112,"@type":113},"They are associated with strong immunomodulatory activity and tissue regeneration abilities, supporting their potential in cancer therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the “double-edged sword” effect refer to in colorectal cancer (CRC)?",{"text":117,"@type":113},"MSC activity can both inhibit and promote CRC progression, with reports showing reduced cancer-cell proliferation and invasion in some studies and tumor-promoting impacts in others.",{"name":119,"@type":110,"acceptedAnswer":120},"How are MSC-derived exosomal microRNAs (MSCs-Exo-miRs) connected to the paradoxical MSC effects?",{"text":121,"@type":113},"Recent investigations suggest MSCs-Exo-miRs contribute to the observed paradoxical effects in CRC progression and may influence therapeutic outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340218,1790742693,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","REVIEW GASTROINTESTINAL TRACT  \nThe Double-Edged Sword Property of Mesenchymal Stem Cell-Derived Exosomal microRNAsin Colorectal Cancer  \nHongliang Yao, Caihua Sun, Chengjun Wang, Jipan Liu, Yun Li, Li Li, Bin Zhao, Jia Liu The Second Department of General Surgery, Hengshui People’s Hospital, Hengshui, Hebei Province, China  \nCite this article as: Yao H, Sun C, Wang C, et al. The double-edged sword property of mesenchymal stem cell-derived exosomal microRNAs in colorectal cancer. Turk J Gastroenterol. 2024;35(10):755-762 .  \nABSTRACT  \nMesenchymal stem cells (MSCs)-based therapies are promising therapeutic strategies for cancer treatment, because of their strong immunomodulatory and tissue regeneration abilities. In case of colorectal cancer (CRC), MSCs indicate a double-edged sword activity. Some reports declared the inhibitory effects of MSCs on the proliferation, migration, and infiltration of cancer cells to suppress the CRC initiation and development, whereas others showed the tumor-promoter impacts of MSCs on the progression of CRC. Recent investigations have revealed that exosomal microRNAs (Exo-miRs) derived from MSCs (MSCs-Exo-miRs) are attributed to such paradoxical effect. Thus, the current review aimed to seek the role of MSCs-Exo-miRs in CRC progression and their therapeutic potential for the CRC treatment.  \nKeywords: Colorectal cancer, exosome, mesenchymal stem cells, microRNA  \nINTRODUCTION  \nColorectal cancer (CRC), as a malignancy beginning from the rectum and/or colon, is the third most common cancer in terms of diagnosis (6 . 1%) and second in terms of cancer-related deaths (9 . 2%) . Rectal and colon cancers constitute approximately 28% and 72% of all CRC incidences respectively. It is estimated that the overall numbers of rectal and colon cancer-caused mortality will elevate to about 71% and 60% respectively, by the year 2035.1  \nVarious risk factors are involved in CRC progression, including non-modifiable and modifiable risk factors. Notably, individuals cannot control non-modifiable risk factors. These include family history as well as personal and medical history, such as ethnicity, race, age, sex, history of inflammatory bowel disease, adenomatous polyps history, cholecystectomy, diabetes, and gut microbiome. On the other hand, modifiable risk factors include environmental factors and lifestyles or individual habits, such as physical inactivity, obesity, overweight, alcohol consumption, cigarette smoking, and unsuitable dietary habits.2 Near to 96% of CRC incidences present as adenocarcinoma, which stems from the secretory epithelial cells covering the surface of the inner cavity of the rectum and/or colon. Indeed, CRC progresses once these cells acquire a series of epigenetic or genetic changes  \ninducing excessive proliferation.2 These hyperproliferative cells develop into a benign adenoma called polyps, which eventually advance to invasive carcinoma termed adenocarcinoma and migrate to various distant tissues through blood and lymphatic arteries.2 Same as other cancers, CRC is classified from stage 0 to stage IV. Excessive proliferation leads to adenoma or polyps (a benign tumor), forming stage 0. Close to 10% of adenomatous polyps may develop into adenocarcinoma invading the muscularis propria (stage I). At stages II and III, the tumor volume is elevated and accordingly invades the serosa and visceral peritoneum respectively. Eventually, at stage IV, it will metastasize through blood or lymphatic vessels.2 Of note, the stage of CRC determines the disease’s severity and the suitable approaches for CRC treatment. For stages 0-II CRC, the standard therapeutic option is surgery. For stage III CRC, surgery and adjuvant chemotherapy, and for stage IV and recurrent CRC, surgery, chemotherapy, and targeted therapy are preferred.2 Despite available therapeutic options, there is no fully effective treatment approach yet.3,4  \nThe first lines of treatment for CRC are surgery, chemotherapy, radiotherapy, and","cbCaii9JK6aVb76Y","https://ap.wps.com/l/cbCaii9JK6aVb76Y","pdf",692602,"English","# Abstract\n# Introduction\n## CRC overview and risk factors\n## Staging and treatment options\n## Current therapies and limitations\n## Emerging therapeutic approaches","[{\"question\":\"Why are mesenchymal stem cell (MSC)-based therapies considered promising for cancer treatment?\",\"answer\":\"They are associated with strong immunomodulatory activity and tissue regeneration abilities, supporting their potential in cancer therapy.\"},{\"question\":\"What does the “double-edged sword” effect refer to in colorectal cancer (CRC)?\",\"answer\":\"MSC activity can both inhibit and promote CRC progression, with reports showing reduced cancer-cell proliferation and invasion in some studies and tumor-promoting impacts in others.\"},{\"question\":\"How are MSC-derived exosomal microRNAs (MSCs-Exo-miRs) connected to the paradoxical MSC effects?\",\"answer\":\"Recent investigations suggest MSCs-Exo-miRs contribute to the observed paradoxical effects in CRC progression and may influence therapeutic outcomes.\"}]","The Double-Edged Sword Property of Mesenchymal Stem Cell-Derived Exosomal microRNAs in Colorectal Cancer - Review Gastrointestinal Tract | PDF",1790035007,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e27def7613cec4e182f6a3cd26314cf.webp",983,1280,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12f28f8c65db377c2b2c8741cd5bfff3.webp",982,1278,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f13e994c5185f831e459a0bec1c4042.webp",981,1277,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09dacf803f6e911e149e3af1e7b66e20.webp",980,1276]